ReviewCurrent atherosclerosis reports2015
Continuation of Dual-Antiplatelet Therapy Following Percutaneous Revascularization with a Drug-Eluting Stent: What Duration Is Optimal?
Rupa K Patil et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it